Santhera Pharmaceuticals
Developing innovative medicines
- B2B
About Santhera Pharmaceuticals
Swiss pharmaceutical company focusing on developing innovative treatments for rare neuromuscular and pulmonary diseases, including vamorolone for DMD and lonodelestat for CF
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 51–250 employees
- Headquarters
- Pratteln, Basel-Country, Switzerland
- Founded
- 2004
- Revenue
- CHF 77.2MFY2025, publicly reported
- Website
- santhera.com
Santhera Pharmaceuticals at a glance
Santhera Pharmaceuticals is a B2B company in the Pharmaceutical Manufacturing industry, headquartered in Pratteln, Basel-Country, Switzerland.
Santhera Pharmaceuticals was founded in 2004.
Santhera Pharmaceuticals has 51–250 employees.
Santhera Pharmaceuticals's revenue is CHF 77.2M (FY2025, publicly reported).
Selling to companies like Santhera Pharmaceuticals?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies